Sign in Subscribe

Edwards Lifesciences Gets Big Boost as CMS Expands TAVR Coverage to Asymptomatic Patients

TAVR is Edwards’ main business. New CMS rules could boost sales and help it take market share from Medtronic and Boston Scientific.

Edwards Lifesciences Gets Big Boost as CMS Expands TAVR Coverage to Asymptomatic Patients
"An Edwards Lifesciences Corp. SAPIEN transcatheter heart valve." Credit: Tim Rue/Bloomberg
Already have an account? Sign in.